Status:
COMPLETED
Long-term Outcome of Punctate Inner Choroidopathy or Multifocal Choroiditis With Active Choroidal Neovascularization Managed With Anti-vascular Endothelial Growth Factor
Lead Sponsor:
Changhua Christian Hospital
Conditions:
Choroidal Neovascularization
Punctate Inner Choroidopathy
Eligibility:
All Genders
Brief Summary
To evaluate the long-term outcome of active choroidal neovascularization (CNV) in punctate inner choroidopathy (PIC) or multifocal choroiditis (MFC) after anti-vascular endothelial factor treatment.
Detailed Description
To evaluate the long-term outcome of active choroidal neovascularization (CNV) in punctate inner choroidopathy (PIC) or multifocal choroiditis (MFC) after anti-vascular endothelial factor treatment. ...
Eligibility Criteria
Inclusion
- Patients were punctate inner choroidopathy or multifocal choroiditis with active choroidal neovascularization.
- Follow up over 4 years.
Exclusion
- Patients were not punctate inner choroidopathy or multifocal choroiditis with active choroidal neovascularization
- Patients were punctate inner choroidopathy or multifocal choroiditis with active choroidal neovascularization but loss follow over 1 year.
Key Trial Info
Start Date :
March 13 2018
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 28 2018
Estimated Enrollment :
22 Patients enrolled
Trial Details
Trial ID
NCT03793400
Start Date
March 13 2018
End Date
December 28 2018
Last Update
January 8 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Changhua Christian Hospital
Changhua, Taiwan